4-nitroquinoline-1-oxide has been researched along with abt-510 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hasina, R; Jalil, A; Jones, CL; Kasza, K; Lingen, MW; Martin, LE | 1 |
1 other study(ies) available for 4-nitroquinoline-1-oxide and abt-510
Article | Year |
---|---|
ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis.
Topics: 4-Nitroquinoline-1-oxide; Angiogenesis Inhibitors; Animals; Carcinogens; Carcinoma, Squamous Cell; Disease Models, Animal; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Mice, Inbred CBA; Microvessels; Mouth Neoplasms; Neovascularization, Pathologic; Oligopeptides; Precancerous Conditions; Vascular Endothelial Growth Factor A | 2009 |